Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that it plans to acquire Wood Mackenzie's Life Sciences business. The Life Sciences business comprises of market research, data and analysis on the commercial landscape of the biopharmaceutical industry and the animal health industry. The acquisition is part of Decision Resources Inc.'s overall growth strategy to secure high quality insight and analysis on various sectors of the ever-evolving healthcare industry.

"We are delighted that Decision Resources has decided to acquire Wood Mackenzie's commercial biopharmaceutical research and animal health businesses," said Stephen Halliday, CEO of Wood Mackenzie. "We know these important lines of business will continue to grow and prosper under Decision Resources Inc.'s watch and they will ably provide our clients with the same integrity and quality of service that Wood Mackenzie adhered to."

"Decision Resources Inc. is pleased to be the new home for the Wood Mackenzie Life Sciences business," said Peter Hoenigsberg, CEO of Decision Resources, Inc. "Wood Mackenzie's quality insights and research adds yet another layer of expertise to our growing healthcare analysis businesses."

Wood Mackenzie's Life Sciences business unit will be folded into Decision Resources, a business unit of Decision Resources Inc. that provides market research and advisory services on significant drug markets.

"Wood Mackenzie's key product lines provide a level of commercial insight into the biopharmaceutical industry that is important to our overall product portfolio," said Sarah Fuller, President of Decision Resources. "For example, their insight on timely events within healthcare will add a longer term view to our clinical expertise as well as help shape our analysis of the commercial side of the pharmaceutical industry - an area we consider a major growth opportunity for us."

  The acquisition is expected to be finalized by the end of the year.    About Wood Mackenzie 

Wood Mackenzie has been providing its unique range of consulting services and research products to the Energy and Life Sciences industries for over 30 years. With our foundation in quality analysis, our detailed industry understanding and our wealth of experience, Wood Mackenzie is able to offer clients a unique skill combination that sets us apart from other solution providers. Our market proposition is based on our ability to provide forward- looking commercial insight that enables our clients to make better business decisions. Wood Mackenzie will retain its Energy business.

About Decision Resources, Inc.

Decision Resources, Inc. is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The Company currently has three business units including HealthLeaders-InterStudy, the leading provider of managed care industry intelligence; Millennium Research Group, the global authority on medical device market intelligence; and Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues. You can visit the companies' web sites at www.DecisionResources.com, www.MRG.net and www.Healthleaders-Interstudy.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:   Elizabeth Marshall   Decision Resources, Inc.   781-296-2563   emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Driven By Genentech/Roche/Chugai's Avastin, the Ovarian Cancer Drug Market Will More Than Triple to $1.6 Billion by 2016

View Now